SHELDON, H.; DUNCAN, N.; SINGH, A.; ENDRIZZI, S.; CONRARDY, R.; BRAZAUSKAS, R.; PEPPARD, W. Naloxone coprescribing best practice advisory for patients at high risk for opioid-related adverse events. Journal of Opioid Management, [S. l.], v. 20, n. 6, p. 471–486, 2024. DOI: 10.5055/jom.0866. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/3744. Acesso em: 22 dec. 2024.